The Food and Drug Administration (FDA)
requests Office of Management and Budget (OMB) approval to conduct
in-person and Web-based surveys of lesbian, gay, bisexual, and
transgender (LGBT) young adults 18 to 24 years old in the United
States, as the Research and Evaluation Survey for the Public
Education Campaign on Tobacco among LGBT (RESPECT). These surveys
will be fielded for purposes of evaluating FDA’s [LGBT Campaign]
public education campaign for LGBT young adults. The primary
outcome evaluation will consist of a baseline survey and
cross-sectional surveys at six-month intervals following the
campaign launch in campaign and control cities. In addition, the
cross-sectional surveys will include an embedded longitudinal
cohort. Data from this evaluation will be used to gauge campaign
awareness and examine the statistical relationships between
exposure to the campaign and changes in outcome variables of
interest.
The Food and Drug
Administration is submitting this extension request to add a
Follow-up 6 to our data collection schedule and refine the data
collection documents for Follow-up 6. Follow-Up 6 is scheduled for
May 2019 through August 2019. During this follow-up data collection
effort, we will continue to re-contact participants and recruit new
respondents to offset attrition. The media tracking ICs were
removed because they were not needed for the information
collection. This led to a decrease in 2,169 responses and 471
hours. The addition of Follow-up 6 increases respondents by 3,913
and burden hours by 1,180.
On behalf of this Federal agency, I certify that
the collection of information encompassed by this request complies
with 5 CFR 1320.9 and the related provisions of 5 CFR
1320.8(b)(3).
The following is a summary of the topics, regarding
the proposed collection of information, that the certification
covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a
benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control
number;
If you are unable to certify compliance with any of
these provisions, identify the item by leaving the box unchecked
and explain the reason in the Supporting Statement.